These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25963982)

  • 21. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.
    Cilli F; Aydemir S; Tunger A
    J Chemother; 2006 Feb; 18(1):27-32. PubMed ID: 16572890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
    Pankey G; Ashcraft D; Patel N
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.
    Entenza JM; Giddey M; Vouillamoz J; Moreillon P
    Int J Antimicrob Agents; 2010 May; 35(5):451-6. PubMed ID: 20185277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
    Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftaroline Plus Ampicillin Against Gram-Positive Organisms: Results from E-Test Synergy Assays.
    D'Arezzo S; Mazzarelli A; Venditti C; Nisii C; Petrosillo N; De Giuli C; Vulcano A; Paglia MG; Bordi E; Di Caro A; Taglietti F
    Microb Drug Resist; 2017 Jun; 23(4):507-515. PubMed ID: 27526275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.
    Kelesidis T; Humphries R; Uslan DZ; Pegues DA
    Clin Infect Dis; 2011 Jan; 52(2):228-34. PubMed ID: 21288849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
    Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
    Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of daptomycin against vancomycin-resistant enterococci of various Van types and comparison of susceptibility testing methods.
    Jorgensen JH; Crawford SA; Kelly CC; Patterson JE
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3760-3. PubMed ID: 14638478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of High-level Gentamicin Resistance among
    Labibzadeh M; Kaydani GA; Savari M; Ekrami A
    Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline.
    Sakoulas G; Nonejuie P; Nizet V; Pogliano J; Crum-Cianflone N; Haddad F
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4042-5. PubMed ID: 23689728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium.
    el-Mady A; Mortensen JE
    Diagn Microbiol Infect Dis; 1991; 14(2):141-5. PubMed ID: 1651825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries (EASSA Study) to critically important antibiotics.
    de Jong A; Simjee S; Garch FE; Moyaert H; Rose M; Youala M; Dry M;
    Vet Microbiol; 2018 Mar; 216():168-175. PubMed ID: 29519512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
    Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium.
    Rand KH; Houck HJ; Silverman JA
    J Antimicrob Chemother; 2007 May; 59(5):1017-20. PubMed ID: 17369277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.